We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FRPT:NASDAQFreshpet, Inc. Analysis

Data as of 2026-09-16 - not real-time

$62.16

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

At $62.16, Freshpet, Inc. shows a bullish moving-average alignment, with shorter averages sitting above longer ones. With RSI at 33.3 the momentum picture is approaching oversold, alongside a bearish MACD signal. The recent range runs from support at $61.10 up to resistance at $77.13.
Multiples put this in undervalued territory at a P/E of 16.1. The average analyst target implies 35.5% above today's level. Revenue is growing at 15.5% on a 17.3% profit margin.
Risk scores 6 out of 10, which is elevated for this asset class. With 30-day volatility of 55.3%, a beta of 0.49 and a maximum drawdown of 44.6%, position sizing matters here. The wider market backdrop reads extreme greed at 91 on the fear-greed composite.
All three time horizons resolve to buy, carrying 7/10 conviction.

Top Market Events

Pet food company Freshpet NASDAQ:FRPT in Q2 CY2026, with sales up 15.Yahoo Finance1monIs Freshpet FRPT Undervalued After Strong Q2 Earnings And Raised 2026 Guidance?Why Freshpet stock is in focus after its latest earnings Freshpet FRPT is back on investor radar after its 5 August...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading below the 200-day average of 63.77
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading below the 200-day average of 63.77
  • Analyst targets imply +35.5% versus the current price

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst targets imply +35.5% versus the current price
  • Profit margin of 17.3% is healthy
  • Revenue growth of +15.5%

Key Metrics & Analysis

Financial Health

Revenue Growth15.50%
Profit Margin17.28%
P/E Ratio16.1
ROE17.62%
ROA3.49%
Debt/Equity39.88
P/B Ratio2.4
Op. Cash Flow$206.6M
Free Cash Flow$19.3M

Technical Analysis

TrendBullish
RSI33.3
Support$61.10
Resistance$77.13
MA 20$69.82
MA 50$65.20
MA 200$63.77
MACDBearish
VolumeDecreasing
Fear & Greed Index91.3

Valuation

Fair Value$6.39
Target Price$84.25
Upside/Downside35.54%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.49
Volatility55.30%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.